Australian Chemicals Stock News

Silver Mines (ASX:SVL) is back in the spotlight after fresh delays to its Bowdens Silver Project, with the NSW Court of Appeal voiding prior approval and forcing new ecological surveys under updated biodiversity rules. See our latest analysis for Silver Mines. Despite the latest court setback, Silver Mines has delivered a powerful year to date, with a 143.59% share price return and a 137.5% one year total shareholder return. However, momentum has cooled in recent weeks as investors reassess...

Mineral Resources (ASX:MIN) has jumped back onto investors radar after lithium prices spiked on Chinese supply disruptions, just as its Onslow Iron project hit nameplate capacity and delivered record quarterly shipments. See our latest analysis for Mineral Resources. Those lithium tailwinds and Onslow Iron milestones help explain why Mineral Resources has a 30 day share price return of 17.7 percent and a 1 year total shareholder return of 64.65 percent. Even though its 3 year total...

Despite the fact that Pathkey.AI Ltd's (ASX:PKY) value has dropped 11% in the last week insiders who sold AU$564k worth...

Viewing insider transactions for Eclipse Metals Limited's ( ASX:EPM ) over the last year, we see that insiders were net...

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, if...

Insiders who bought AU$798.2k worth of Resources & Energy Group Limited's ( ASX:REZ ) stock at an average buy price of...

Anax Metals Limited ( ASX:ANX ) insiders who purchased shares in the last 12 months were richly rewarded last week. The...

Vault Minerals' (ASX:VAU) stock is up by a considerable 28% over the past three months. Given the company's impressive...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Artrya Limited recently announced a five-year SaaS agreement with U.S. healthcare provider Cone Health to roll out its Salix Coronary Anatomy and Plaque AI imaging modules across the health system’s network, securing its third commercial customer in the United States. This latest deal completes the conversion of all three of Artrya’s U.S. foundation partners, signalling growing clinical adoption and a deeper foothold in the competitive American cardiac imaging market. We’ll now examine how...

EOS stock jumps on landmark defense contracts Electro Optic Systems Holdings (ASX:EOS) is back on investor radars after securing an $80 million laser weapon deal with South Korea and a $22 million US Army contract, sharply improving revenue visibility. See our latest analysis for Electro Optic Systems Holdings. Those December defense wins cap an extraordinary run, with the share price delivering a year to date return of around 609 percent and a 1 year total shareholder return of about 677...

Latest move in Woodside Energy Group shares Woodside Energy Group (ASX:WDS) has slipped about 8% over the past month, even though the stock is roughly flat over the past 3 months and modestly higher over the past year. See our latest analysis for Woodside Energy Group. That recent 1 month share price return of about negative 8% stands in contrast to a mildly positive 1 year total shareholder return. This suggests momentum has cooled as investors reassess growth prospects and near term...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

We wouldn't blame Brazilian Rare Earths Limited ( ASX:BRE ) shareholders if they were a little worried about the fact...

With the business potentially at an important milestone, we thought we'd take a closer look at Vintage Energy Limited's...

As the Australian market approaches the holiday season, it's experiencing a slight dip, likely due to profit-taking and early closures, while Wall Street indices near record highs. In this environment of cautious optimism, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those who know the business best.

As the Australian market edges towards the holiday season with a slight dip, largely due to profit-taking and early closures, investors are keeping an eye on small-cap stocks amidst broader market fluctuations. In this environment, identifying promising yet overlooked companies can be key to enhancing your investment portfolio, especially as these gems may offer unique opportunities in times of economic shifts.

As the Australian market winds down for the holiday season, with a slight dip of 0.2% attributed to profit-taking before the break, investors are keeping an eye on precious metals and commodities. For those willing to explore beyond established names, penny stocks—despite their vintage moniker—remain a relevant investment area that can offer unique opportunities. This article highlights three standout penny stocks on the ASX that demonstrate financial strength and potential for long-term...

Wesfarmers (ASX:WES) is back in focus after more than 50 Priceline pharmacies tied to Infinity Pharmacy Group went into administration, which has sharpened attention on execution risks in its expanding health and pharmacy division. See our latest analysis for Wesfarmers. The latest concerns around Infinity Pharmacy Group land at a time when Wesfarmers’ A$81.56 share price is already consolidating after a weaker 90 day share price return, even as its one year total shareholder return of 18.95...

4DMedical (ASX:4DX) just signed a commercial deal with the Cleveland Clinic for its CT:VQ imaging platform, and investors are taking notice as deployments accelerate across leading U.S. academic hospitals. See our latest analysis for 4DMedical. The market clearly sees this Cleveland Clinic deal as validation, with a 30 day share price return of roughly 149 percent and a one year total shareholder return above 760 percent. This points to strong, momentum driven optimism about 4DMedical’s long...

Goodman Group (ASX:GMG) has just locked in a 50:50, A$14 billion European data centre partnership with CPP Investments, targeting Frankfurt, Amsterdam and Paris at a time when cloud and AI driven demand continues to climb. See our latest analysis for Goodman Group. That announcement helps explain why momentum has swung back in Goodman’s favour, with a 7 day share price return of 10.36 percent and a three year total shareholder return of 88.13 percent despite a softer year to date. If...

Earlier this week, HMC Capital was removed from the ASX 200 index, triggering mandated portfolio adjustments for index-tracking funds and benchmark-aware managers. This index exclusion is drawing fresh attention to how passive selling and benchmark status can influence liquidity, ownership mix, and investor perceptions of HMC Capital. We’ll now explore how HMC Capital’s removal from the ASX 200 index interacts with its longer-term investment narrative and growth plans. Outshine the giants:...

Meteoric Resources (ASX:MEI) has jumped into focus after securing a preliminary environmental licence for its Caldeira rare earths project in Brazil, clearing a key regulatory hurdle without extra conditions attached. See our latest analysis for Meteoric Resources. The licence win has arrived on the back of strong momentum, with a 7 day share price return of 20 percent, a 90 day gain of 28.57 percent, and a 1 year total shareholder return of 109.3 percent. This signals that investors are...